South Africa, Eswatini, and Zambia were to begin on Monday administering a groundbreaking new HIV-prevention injection in the drug’s first public rollouts in Africa, which has the world’s highest HIV burden. Lenacapavir, taken twice a year, has been shown Read more…
Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 countries from 2027, Unitaid and the Gates Foundation said Wednesday. The two organisations have entered into separate agreements with Indian pharmaceutical Read more…